A generic approach for the determination of residues of alkylating agents in active pharmaceutical ingredients by in situ derivatization-headspace-gas chromatography-mass spectrometry.
暂无分享,去创建一个
Roman Szucs | Pat Sandra | P. Sandra | R. Szucs | R. Alzaga | Karen Taylor-Worth | A. Lipczynski | Karen Taylor-Worth | Roberto Alzaga | Robert W Ryan | Andrew M Lipczynski | Robert W. Ryan
[1] J. Goldie,et al. Gas-chromatographic analysis of busulfan for therapeutic drug monitoring , 2004, Cancer Chemotherapy and Pharmacology.
[2] G. Carrera,et al. Static headspace gas chromatographic method for quantitative determination of residual solvents in pharmaceutical drug substances according to european pharmacopoeia requirements. , 2004, Journal of chromatography. A.
[3] L. Hansen,et al. Dimethyl sulfate in particulate matter from coal- and oil-fired power plants , 1981 .
[4] H. Kubo,et al. QUANTITATIVE DETERMINATION OF BUSULFAN IN SERUM USING GAS CHROMATOGRAPHY– MASS SPECTROMETRY IN NEGATIVE-ION CHEMICAL IONIZATION MODE , 2001 .
[5] Weiyong. Li. Trace analysis of residual methyl methanesulfonate, ethyl methanesulfonate and isopropyl methanesulfonate in pharmaceuticals by capillary gas chromatography with flame ionization detection. , 2004, Journal of chromatography. A.
[6] J. Rusling,et al. Voltammetric sensor for chemical toxicity using [Ru(bpy)2poly(4-vinylpyridine)10Cl)+ as catalyst in ultrathin films. DNA damage from methylating agents and an enzyme-generated epoxide. , 2003, Analytical chemistry.
[7] M. Niess,et al. Isotachophoretic separation of alkylsulfonates and determination of methanesulfonic acid as main component and as trace component in pharmaceutical drug substances. , 2004, Journal of chromatography. A.
[8] L. Grochow,et al. Determination of busulfan in human plasma by gas chromatography with electron-capture detection. , 1988, Journal of chromatography.
[9] H G Ramjit,et al. Gas chromatographic/mass spectrometric analysis of methyl methanesulphonate and ethyl methanesulphonate in the bismesylate salt of DPI 201-106, a positive inotropic agent for the treatment of heart failure. , 1996, Journal of mass spectrometry : JMS.
[10] Lutz Müller,et al. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. , 2006, Regulatory toxicology and pharmacology : RTP.
[11] C. B'hymer,et al. Residual Solvent Testing: A Review of Gas-Chromatographic and Alternative Techniques , 2003, Pharmaceutical Research.
[12] D. Snodin,et al. Residues of genotoxic alkyl mesylates in mesylate salt drug substances: real or imaginary problems? , 2006, Regulatory toxicology and pharmacology : RTP.
[13] S. Klick,et al. Validation of a generic analytical procedure for determination of residual solvents in drug substances. , 2004, Journal of pharmaceutical and biomedical analysis.
[14] L. Blomberg,et al. On-Line Derivatization Utilizing Solid-Phase Microextraction (SPME) for Determination of Busulphan in Plasma Using Gas Chromatography–Mass Spectrometry (GC-MS) , 2003, Therapeutic drug monitoring.
[15] R. E. Carlson,et al. Determination of potentially mutagenic and carcinogenic electrophiles in environmental samples , 1981 .
[16] L. Embree,et al. A gas-chromatographic assay method for busulfan with sensitivity for test dose therapeutic monitoring. , 1995, Journal of pharmaceutical and biomedical analysis.
[17] E. Doelker,et al. Residual solvents in pharmaceutical products: acceptable limits, influences on physicochemical properties, analytical methods and documented values , 1997 .
[18] K. Arizono,et al. A rapid and sensitive analysis of diphenylarsinic acid in water by gas chromatography/mass spectrometry. , 2005, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
[19] W. Lambert,et al. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid , 2003, Journal of the American Society for Mass Spectrometry.
[20] M. Chandy,et al. Quantification of busulfan in plasma by gas chromatography-mass spectrometry following derivatization with tetrafluorothiophenol. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[21] J. Bayona,et al. Determination of perfluorocarboxylic acids in aqueous matrices by ion-pair solid-phase microextraction-in-port derivatization-gas chromatography-negative ion chemical ionization mass spectrometry. , 2004, Journal of chromatography. A.
[22] J. Rusling,et al. Quantitative measurement of DNA adducts using neutral hydrolysis and LC-MS. Validation of genotoxicity sensors. , 2005, Analytical chemistry.
[23] N. Snow,et al. Head-space analysis in modern gas chromatography , 2002 .
[24] J. D. Stuart,et al. Toxicity screening by electrochemical detection of DNA damage by metabolites generated in situ in ultrathin DNA-enzyme films. , 2003, Journal of the American Chemical Society.
[25] F. Brion,et al. Separation methods for alkylating antineoplastic compounds. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[26] A. Verdeguer,et al. Determination of busulfan in human plasma using high-performance liquid chromatography with pre-column derivatization and fluorescence detection. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[27] I. Colón,et al. Determination of methyl and ethyl esters of methanesulfonic, benzenesulfonic and p-toluenesulfonic acids in active pharmaceutical ingredients by solid-phase microextraction (SPME) coupled to GC/SIM-MS. , 2005, Journal of pharmaceutical and biomedical analysis.
[28] A. Krstulović,et al. Determination of polar alkylating agents as thiocyanate/isothiocyanate derivatives by reaction headspace gas chromatography , 2003 .
[29] Walter A. Korfmacher,et al. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery. , 2003, Rapid communications in mass spectrometry : RCM.